Buscar
🇪🇸
MEM
O
RY
.COM
4.37.48
Invitado
Iniciar sesión
Página de inicio
0
0
0
0
0
Crear curso
Cursos
Último juego
Panel
Notificaciones
Clases
Carpetas
Exámenes
Exámenes personalizados
Ayuda
Marcador
Tienda
Premios
Amigos
Asignaturas
Modo oscuro
Identificador de usuario: 999999
Versión: 4.37.48
www.memory.es
Estás en modo de exploración. debe iniciar sesión para usar
MEM
O
RY
Inicia sesión para empezar
Index
»
PHARMACOLOGY 2
»
LIPIDS DISORDER
»
Level 1
level: Level 1
Questions and Answers List
level questions: Level 1
Question
Answer
EXOGENOUS PATHWAY 1 are formed from dietary triglycerides and cholesterol 2 ➢In adipose tissue and muscle, the enzyme __ removes the triglycerides, leaving chylomicron remnants containing intact cholesterol esters. 3 ➢When chylomicron remnants reach the liver, they are taken up by hepatocytes and then cleaved, releasing __
. 1 Chylomicrons 2 lipoprotein lipase 3 free cholesterol.
Endogenous pathways 1 __ is formed in the liver from triglycerides and cholesterol, generally as a result of high caloric intake. VLDL is released into the plasma, where lipoprotein lipase cleaves the triglycerides from VLDL 2 The hydrolysis of VLDL produces __
. 1 Very low-density lipoprotein (VLDL) 2 intermediate-density lipoprotein (IDL).
1 involved in the transport of endogenous cholesterol ester to the liver or to extrahepatic tissues. __ constitutes 60%-70% of plasma cholesterol levels. 2 is involved in the transport of cholesterol from peripheral cells back to the liver
1 LDL 2 High-density lipoprotein (HDL)
Nonspecific pathways. ➢When plasma lipoprotein concentrations are high, macrophages and other scavenger cells take part in lipoprotein degradation. ➢This leads to cholesterol deposits in __ and __
1 macrophages or arterial walls (atheromas) 2 of tendons and skin (xanthomas).
Antihyperlipidemic agents
1 HMG CoA Reductase Inhibitors 2 Bile Acid sequestrants 3 Niacin 4 Fibric Acid derivatives 5 Probucol